Department of Pediatric Cardiovascular Surgery, Children's Research Hospital, Kyoto Prefectural University of Medicine, Kyoto, Japan.
J Thorac Cardiovasc Surg. 2011 Nov;142(5):1122-9. doi: 10.1016/j.jtcvs.2011.08.018. Epub 2011 Sep 9.
There is no optimal substitute for right ventricular outflow tract (RVOT) reconstruction in congenital heart defects. Expanded polytetrafluoroethylene (ePTFE) valved conduits and patches may be a good alternative to homografts and bovine jugular veins. We have developed a fan-shaped ePTFE valve and an ePTFE valved conduit and patch with bulging sinuses with the aim of enhancing the long-term valve function.
Bulging sinuses were constructed on ePTFE conduits and patches as described previously (J Thorac Cardiovasc Surg. 2007;134:327-32). Between February 2001 and January 2011, 794 patients (aged 14 days to 56.8 years old; median, 2.0 years old) had ePTFE valves implanted for RVOT reconstruction at 52 Japanese institutes. Conduits with a fan-shaped ePTFE valve were implanted in 325 patients and a patch with a fan-shaped ePTFE valve was implanted in 469 patients. Valve function was assessed by a series of echocardiograms postoperatively.
The mean follow-up was 3.6 years (1.1 months to 10.0 years). Freedom from reoperation at 10 years was 95.4% in patients with conduits and 92.3% in those with patches. Pulmonary insufficiency was mild or nonexistent in 95.0% of patients with conduits and 79.6% of patients with patches. The pressure gradient between the right ventricle and the pulmonary artery was 14.0 ± 13.2 mm Hg in patients with conduits and 11.6 ± 11.6 mm Hg in patients with patches.
Fan-shaped ePTFE valved conduits and patches with bulging sinuses have a high freedom from reoperation and prevent pulmonary insufficiency. They represent a promising material for RVOT reconstruction.
在先天性心脏病中,右心室流出道(RVOT)重建没有最佳替代物。膨体聚四氟乙烯(ePTFE)带瓣管道和补片可能是同种移植物和牛颈静脉的良好替代品。我们开发了一种扇形 ePTFE 瓣膜和一种带有窦膨出的 ePTFE 带瓣管道和补片,旨在增强长期瓣膜功能。
如前所述(J Thorac Cardiovasc Surg. 2007;134:327-32),在 ePTFE 管道和补片上构建窦膨出。2001 年 2 月至 2011 年 1 月,52 家日本机构的 794 名患者(年龄 14 天至 56.8 岁;中位数 2.0 岁)接受 ePTFE 瓣膜植入 RVOT 重建。325 名患者植入带有扇形 ePTFE 瓣膜的管道,469 名患者植入带有扇形 ePTFE 瓣膜的补片。术后通过一系列超声心动图评估瓣膜功能。
平均随访时间为 3.6 年(1.1 个月至 10.0 年)。带管道的患者 10 年无再手术率为 95.4%,带补片的患者为 92.3%。带管道的患者中 95.0%和带补片的患者中 79.6%的患者肺功能不全为轻度或不存在。带管道的患者右心室与肺动脉之间的压力梯度为 14.0±13.2mmHg,带补片的患者为 11.6±11.6mmHg。
带有窦膨出的扇形 ePTFE 带瓣管道和补片具有较高的无再手术率,可预防肺功能不全。它们是 RVOT 重建的一种有前途的材料。